Mantle Cell Lymphoma
All Videos
Insights from 2025 Tandem Annual Meeting
Tandem 2025 Insights: Management of Steroid Refractory Acute GVHD
FEATURING
David Jacobsohn
- 2 views
- March 10, 2025
2024 ASH Annual Meeting Insights Hub
Tandem 2025 Summary: Hematologic Toxicities Following CAR-T in Lymphoma Patients
FEATURING
Liffy Cherian
- 3 views
- February 28, 2025
University of Colorado Division of Hematology
ASH 2025 Review: Key Trials and Takeaways in 1L MCL Treatment in Younger and Older Patients
FEATURING
Tycel Phillips
- 29 views
- February 25, 2025
MyCancerHaven
Overview of Liso-Cel Landmark Trials for R/R DLBCL and MCL
FEATURING
Ravi Vij,
Forat Lutfi
- 16 views
- February 14, 2025
GRACE
HSCT & Cell Therapy 101: Overview of Types, Processes, Supportive Care, and Toxicities
FEATURING
Muhammad Salman Faisal
- 20 views
- February 6, 2025
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma
FEATURING
Paolo Caimi
- 191 views
- February 3, 2025
- 1
Chan Cheah
FDA Approval of Acalabrutinib + BR for 1L MCL: Ph3 ECHO Trial & Subgroup Analysis
- 172 views
- January 31, 2025
- 1
Louisville Hematology Highlights
Advances in CAR-T Therapy: R/R NHL, R/R MM, Toxicity Management, and Future Directions
FEATURING
Joseph Maakaron
- 17 views
- January 31, 2025
Louisville Hematology Highlights
Updates and Treatment Approach for R/R FL and R/R MCL
FEATURING
Farrukh Awan
- 10 views
- January 31, 2025
Elisabetta Xue
Identifying Steroid-Refractory or Steroid-Dependent cGVHD and the Role of Ruxolitinib
- 49 views
- January 30, 2025
GRACE
Common Toxicities Associated With Allogeneic HSCT
FEATURING
Muhammad Salman Faisal
- 11 views
- January 30, 2025
Moffitt Cancer Center
Updates on Approved CAR-Ts for Lymphomas
FEATURING
Julio Chavez
- 128 views
- January 28, 2025
- 1
Roswell Park Comprehensive Cancer Center
Steroid-Refractory GVHD Updates
FEATURING
Shernan Holtan
- 192 views
- January 24, 2025
City of Hope
Acute GVHD: Demographics, Diagnosis, Pathophysiology, and Advancements in Treatment With Corticosteroids & JAK Inhibitors
FEATURING
Amandeep Salhotra
- 97 views
- January 22, 2025
- 1
Penn Medicine Abramson Cancer Center
Advancing Lymphoma Treatment Options: From Bispecific Antibodies to CAR T-Cell Therapy
FEATURING
Michael Cook
- 18 views
- January 6, 2025
Giuseppe Francesco Milone
The Evolving Landscape of cGVHD Treatment Options
- 44 views
- December 27, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Zanubrutinib in Acalabrutinib-Intolerant Patients With B-Cell Malignancies
FEATURING
Mazyar Shadman
- 93 views
- December 18, 2024
- 2
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Acalabrutinib, Venetoclax, and Obinutuzumab in Patients With MCL - MAVO Phase 1/2 Study
FEATURING
Austin Kim
- 36 views
- December 13, 2024
Fox Chase Cancer Center
Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN Trial
FEATURING
Shazia Nakhoda
- 69 views
- December 13, 2024
Oncology Data Advisor
Lymphoma Awareness Month: Nursing and Patient Advocacy Perspectives
FEATURING
Maria Badillo,
Lauren Ghazal
- 1 view
- November 26, 2024
Noah Merin
Axatilimab in cGVHD: Mechanism of Action and Comparison With Current Therapeutic Agents
- 123 views
- November 10, 2024
Najla El-Jurdi
CSF1R's Role in Modulating Inflammation & Fibrosis in cGVHD
- 44 views
- October 16, 2024
Brittany Ragon
Targeting cGVHD: Mechanism of Action of Axatilimab Compared to Other Available Agents
- 30 views
- October 14, 2024
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 39 views
- October 7, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in the Treatment of MCL
FEATURING
Georg Hess
- 306 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Updates on Mantle Cell Lymphoma
FEATURING
Elif Ateşoğlu
- 48 views
- September 27, 2024
- 1
Yale Cancer Center
Caring for Patients With Lymphoma: Using Guidelines to Improve Quality of Care
FEATURING
Scott Huntington,
Eric Winer
- 85 views
- September 11, 2024
Daniel Wolff
The Role of Axatilimab in Targeting CSF1R for Inflammation and Fibrosis in cGVHD – Recently FDA Approved
- 173 views
- September 6, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: HL, DLBCL, MCL
FEATURING
Alexandra Rojek
- 141 views
- September 4, 2024
- 3
MyCancerHaven
Recent Updates on Liso-Cel in R/R DLBCL & MCL
FEATURING
Ravi Vij,
Forat Lutfi
- 47 views
- August 30, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Case Discussion: Managment of High-Risk MCL
FEATURING
Ahmet Mert Yanık
- 28 views
- August 15, 2024
Robert Zeiser
CSF1R's Role in Modulating Inflammation and Fibrosis in cGVHD
- 61 views
- August 13, 2024
- 1
Integrity CE
Treatment Updates and Management of Non-Hodgkin Lymphomas
FEATURING
Danielle Wallace,
Matthew Cortese
- 117 views
- August 7, 2024
- 1
UChicago Medicine
The Next Frontier of Targeted Therapy in Lymphoma
FEATURING
Kami Maddocks
- 240 views
- July 22, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Sonrotoclax and Zanubrutinib Combination Therapy for R/R MCL
FEATURING
Constantine Tam
- 27 views
- July 18, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"
FEATURING
Yucai Wang
- 70 views
- July 11, 2024
- 1
SOHO Brazil 2024
Making Sense of 1L Treatment Options in MCL
FEATURING
Tycel Phillips
- 123 views
- July 11, 2024
- 1
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
FEATURING
Wojciech Jurczak
- 44 views
- June 30, 2024
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
FEATURING
Leo Gordon
- 399 views
- June 28, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
FEATURING
Bruce D. Cheson
- 1,688 views
- June 19, 2024
- 2
Rush University Medical Center
Optimal Timing of CAR T-Cell Therapies in MCL: Cellular Therapy and Beyond
FEATURING
Sunita Nathan
- 21 views
- June 13, 2024
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in Indolent B-Cell Lymphomas
FEATURING
Jake Soumerai
- 523 views
- June 5, 2024
- 1
Yale Cancer Center
Case-Based Discussions in Lymphoma: 1L MCL, CD30+ T-Cell, and R/R CLL
- 102 views
- May 14, 2024
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL, FL, and CLL/SLL
FEATURING
Shalin Kothari
- 132 views
- May 13, 2024
MyCancerHaven
CLL and MCL: Experts Discuss the Use of Pirtobrutinib
FEATURING
Ravi Vij,
Geoffrey Shouse
- 243 views
- May 7, 2024
- 2
University of Miami Sylvester Comprehensive Cancer Center
Evaluating Zanubrutinib + Tafasitamab in MCL
FEATURING
Alvaro Alencar
- 29 views
- May 7, 2024
University of Miami Sylvester Comprehensive Cancer Center
Using BTKis in MCL Today
FEATURING
Alvaro Alencar
- 69 views
- May 7, 2024
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
FEATURING
Pallawi Torka
- 409 views
- May 2, 2024
Indy Hematology Review
When Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma and MCL
FEATURING
Michael Williams
- 153 views
- April 23, 2024
- 2
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do and Know in Community Oncology Practice
FEATURING
Tycel Phillips
- 157 views
- April 23, 2024
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignancies
FEATURING
Ruemu Birhiray
- 974 views
- April 16, 2024
- 5
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
FEATURING
Manali Kamdar
- 252 views
- April 8, 2024
- 1
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Management of MCL
FEATURING
Andre Goy
- 138 views
- March 27, 2024
- 3
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
FEATURING
Sonali Smith
- 405 views
- March 19, 2024
- 3
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Practical Updates on Advances in CLL and MCL
FEATURING
Elise Chong
- 279 views
- March 13, 2024
- 1
Total Health
Update on Cellular Therapy in Lymphoma
FEATURING
Brion Randolph
- 117 views
- February 27, 2024
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
FEATURING
Robert Peter Gale
- 4,721 views
- February 26, 2024
- 21
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MCL - Highlights & Key Takeaways"
FEATURING
Victor Yazbeck
- 173 views
- January 24, 2024
- 1
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
FEATURING
Amy Zhou
- 955 views
- January 8, 2024
- 6
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Highlights and Key Takeaways in MCL"
FEATURING
Preetesh Jain
- 198 views
- December 15, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Multicenter Study of MCL Outcomes Following 1L BR and 2L BTKi Therapy"
FEATURING
Yucai Wang
- 60 views
- December 13, 2023
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 436 views
- December 13, 2023
- 1
5th SOHO Italy Annual Conference
SOHO Italy 2023: How I Manage Follicular, Marginal Zone and Mantle Cell Lymphoma
FEATURING
Stefano Luminari
- 83 views
- December 1, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Emerging BCL2 Inhibitors
FEATURING
Mary Ann Anderson
- 139 views
- November 21, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: MCL
FEATURING
Andre Goy
- 48 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is High Risk MCL and How Should We Treat It
FEATURING
Anita Kumar
- 194 views
- October 18, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CAR T-Cell Therapy and Bispecific Antibodies in MCL
FEATURING
Tycel Phillips
- 64 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Emerging Novel Agents in Mantle Cell Lymphoma
FEATURING
Kami Maddocks
- 113 views
- October 18, 2023
University of Colorado Division of Hematology
Mantle Cell Lymphoma: Challenges & Prospects
FEATURING
Jagar Jasem
- 216 views
- October 17, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Is Stem Cell Transplantation Still Necessary in Frontline MCL?
FEATURING
Timothy Fenske
- 131 views
- October 17, 2023